2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
I

Targeting Exon 20 Insertions in NSCLC: Anti-Tumor Activity With T-Dxd in HER2m Disease, Assessing Efficacy of Treatment Options in EGFRm Disease

By 2020 ASCO Virtual Direct™ Highlights FEATURING Ibiayi Dagogo-Jack
By 2020 ASCO Virtual Direct™ Highlights FEATURING Ibiayi Dagogo-Jack
0 views
January 28, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Lung
13:52
2020 ASCO Virtual Direct™ Highlights

Targeting Exon 20 Insertions in NSCLC: Anti-Tumor Activity With T-Dx…

Feat. I. Dagogo-Jack
18:53
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on 1L Treatment of ES-SCLC: IO + Chemo - Results fr…

Feat. N. Seetharamu
10:35
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on NSCLC: Neoadjuvant Chemo for Locally Advanced Di…

Feat. N. Seetharamu
22:55
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on 1st Line IO Strategies for Metastatic NSCLC: Sho…

Feat. I. Dagogo-Jack